Cargando…
Identification of NRAS Downstream Genes with CRISPR Activation Screening
SIMPLE SUMMARY: NRAS mutations constitutively activate cell proliferation signaling in malignant tumors. The elucidation of NRAS downstream signaling genes may lead to the control of NRAS-mutant tumors. Genome-wide CRISPR activation screening was performed on THP-1 B11, in which NRAS expression and...
Autores principales: | Tatsumi, Akiya, Hirakochi, Haruka, Inoue, Satomi, Tanaka, Yosuke, Furuno, Hidehiro, Ikeda, Masumi, Ishibashi, Sachiko, Taguchi, Towako, Yamamoto, Kouhei, Onishi, Iichiroh, Sachs, Zohar, Largaespada, David A., Kitagawa, Masanobu, Kurata, Morito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687188/ https://www.ncbi.nlm.nih.gov/pubmed/36358254 http://dx.doi.org/10.3390/biology11111551 |
Ejemplares similares
-
Bone marrow niches in myeloid neoplasms
por: Kitagawa, Masanobu, et al.
Publicado: (2019) -
Overview of Ferroptosis and Synthetic Lethality Strategies
por: Kinowaki, Yuko, et al.
Publicado: (2021) -
CRISPR screening identifies M1AP as a new MYC regulator with a promoter-reporter system
por: Yamamoto, Akiko, et al.
Publicado: (2020) -
To Discover the Efficient and Novel Drug Targets in Human Cancers Using CRISPR/Cas Screening and Databases
por: Onishi, Iichiroh, et al.
Publicado: (2021) -
Efficient Identification of the MYC Regulator with the Use of the CRISPR Library and Context-Matched Database Screenings
por: Tanaka, Yosuke, et al.
Publicado: (2022)